Condition : Osteoporosis, Postmenopausal Intervention : Drug: E2/LNG oral (Wellnara, BAY86-5029) Sponsor : Bayer Recruiting - verified July 2011

Condition : Osteoporosis, Postmenopausal Intervention : Drug: E2 transdermal (Julina, BAY86-5435) Sponsor : Bayer Recruiting - verified July 2011

Condition : Osteoporosis Intervention : Other: Educ sessions & LTC Osteoporosis toolkit Sponsor : McMaster University Recruiting - verified July 2011

Condition : Osteoporosis, Postmenopausal Intervention : Drug: E2 transdermal (Julina, BAY86-5435) Sponsor : Bayer Recruiting - verified August 2011

Conditions : Obesity; Inflammation; Insulin Sensitivity; Osteoporosis Intervention : Dietary Supplement: Resveratrol Sponsors : University of Aarhus; The Ministry of Science, Technology and Innovation...

Conditions : Obesity; Inflammation; Insulin Sensitivity; Osteoporosis Intervention : Dietary Supplement: Resveratrol Sponsors : University of Aarhus; The Ministry of Science, Technology and Innovation...

Conditions : Osteopenia; Osteoporosis Interventions : Drug: BPS804; Drug: placebo; Drug: BPS804; Drug: Placebo Sponsor : Novartis Pharmaceuticals Recruiting - verified July 2011

Conditions : Osteopenia; Osteoporosis Interventions : Drug: BPS804; Drug: placebo; Drug: BPS804; Drug: Placebo Sponsor : Novartis Pharmaceuticals Recruiting - verified July 2011

Condition : Osteoporosis Interventions : Other: case management; Other: Multifaceted quality improvement intervention Sponsor : University of Alberta Not yet recruiting - verified July 2011

Condition : Osteoporosis Interventions : Drug: Nitrates; Other: Placebo Sponsors : University of Toronto; The Physicians' Services Incorporated Foundation; California Pacific Medical Center; Sunnybroo...